HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Tom Dayspring on atherosclerosis development, apoB and biomarkers (The Drive #334)

Gokhan Can · Feb 04, 2025 · ♥ 15 reactions · 8 comments · original Facebook post
LDL, ApoB & lipid panelCardiovascular disease: the big picture
AI summary & key facts

Gokhan summarizes a Peter Attia podcast episode with lipidologist Tom Dayspring on why cardiovascular disease is the leading killer. It covers cholesterol imbalance, inflammation and metabolic factors, plus early detection, diagnostic tools and targeted therapies.

The video, titled "334 - Cardiovascular Disease, the Number One Killer," features renowned clinical lipidology expert Tom Dayspring as he delves into why cardiovascular disease remains the leading cause of death. In the episode, Dayspring explains how factors like cholesterol imbalance, inflammation, and other metabolic irregularities contribute to the development of heart disease. He highlights the importance of early detection and discusses emerging diagnostic tools and targeted therapies that can help manage and potentially mitigate these risks. Overall, the episode offers a detailed yet accessible exploration of cardiovascular health, providing both medical professionals and the general public with valuable insights into prevention and treatment strategies.

▶Video · YouTube · Peter Attia MD334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and moreTom Dayspring is a world-renowned expert in clinical lipidology & a previous guest on The Drive. In this episode, Tom explores the foundations of atherosclerosis & why atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide for both men & women. He examines how the disease develops from a pathological perspective & discusses…youtube.com
#dayspring#cardiovascular#cardiovasculardisease#heartdisease#cardiovascularhealth#atherosclerosis#apob#cholesterol
← newer: Liver disease plus type 2 diabetes has a multiplicative effeolder: Video: immunoglobulin G buildup in fat tissue drives insulin →